DFX Intelligence

Data Factory

Cavalry Biosciences

Engineering nature's growth factors into tissue-selective medicines for eye, muscle and nerve repair. Explore our IGF-1 pipeline and regeneration mission.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:12d1c295-c18b-4c24-9689-40a8aaeec519

Data as of Sep 17, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 19, 2026, 8:01 PM UTC and rebuilt at most every 15 minutes.

Relationships: 1
Dated events: 0
On other graphs: 0
Observed: Sep 15, 2026 to Sep 17, 2026
5 observations

Across DFX

This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Rounds: 0
Investors: 1
People: 0
Website: cavalry.bio

Investors

Investor	Class	Fund	Partner	Role	Attribution
Mission Biocapital	Institutional VC	n/a	n/a	unknown	Unknown

Relationships

Invested in (1)

← Mission BiocapitalFirmPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site

Dated events

No dated event names this entity yet.

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:12d1c295-c18b-4c24-9689-40a8aaeec519
First observed: Sep 15, 2026
Last observed: Sep 17, 2026 2 days ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.